サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1481484

薬剤スクリーニングの世界市場：製品・サービス別、サンプルタイプ別、薬剤タイプ別、エンドユーザー別、地域別 - 2029年までの予測

Drug Screening Market by Product (Rapid Testing (Urine, Oral), Analytical (Breathalyzer, Immunoassay, Chromatography)), Sample (Urine, Breath, Hair), Drug (Alcohol, Cannabis, Opioids), End User (Workplace, Hospital, Law) - Global Forecast to 2029
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 505 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.13円
薬剤スクリーニングの世界市場：製品・サービス別、サンプルタイプ別、薬剤タイプ別、エンドユーザー別、地域別 - 2029年までの予測
出版日: 2024年05月16日
発行: MarketsandMarkets
ページ情報: 英文 505 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の薬剤スクリーニングの市場規模は、16.6%のCAGRで拡大し、2024年の91億米ドルから2029年には195億米ドルに達すると予測されています。

薬剤・アルコール検査を義務付ける厳格な法律の施行、薬剤・アルコール消費の増加、薬剤スクリーニング製品・サービスに対する規制認可の増加などの要因があります。しかし、イスラム諸国におけるアルコール摂取の禁止や、特定の国における職場での薬剤スクリーニングの禁止は、この市場の成長をある程度妨げる可能性があります。

調査範囲
調査対象年 2018年～2029年
基準年 2023年
予測期間 2024年～2029年
検討単位 金額（10億米ドル）
セグメント 製品・サービス別、サンプルタイプ別、薬剤タイプ別、エンドユーザー別、地域別
対象地域 北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ

薬剤スクリーニング市場は、薬剤スクリーニング製品と薬剤スクリーニングサービスに分けられます。世界の薬剤・アルコール消費量の増加、薬剤・アルコール検査機関の地理的拡大、薬剤スクリーニング機関への資金提供イニシアティブ、薬剤スクリーニングに関する厳格な法律、薬剤スクリーニングの承認増加などの要因が市場に寄与しています。

薬剤スクリーニング製品は、分析機器、迅速検査機器、消耗品に分けられます。2023年の薬剤スクリーニング製品市場では、分析機器分野が最大のシェアを占めています。要因としては、アルコール消費量の増加、飲酒運転・飲酒運転の増加、薬剤・アルコール検査を義務付ける政府の厳しい法律、分析機器の技術進歩などが挙げられます。

地域的には、薬剤スクリーニング市場は、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにセグメント化されます。2023年には、北米が薬剤スクリーニング市場の最大シェアを占め、次いで欧州が続きます。しかし、アジア太平洋は予測期間中に最も高い成長率を記録すると考えられています。この地域セグメントの高い成長は、薬剤の不正消費の増加、より頻繁な薬剤スクリーニングを必要とする厳しい規制の実施によるものです。

当レポートでは、世界の薬剤スクリーニング市場について調査し、製品・サービス別、サンプルタイプ別、薬剤タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
  • 顧客のビジネスに影響を与える動向/混乱
  • 業界動向
  • バリューチェーン分析
  • エコシステム分析
  • 技術分析
  • ポーターのファイブフォース分析
  • 主な利害関係者と購入基準
  • 関税および規制分析
  • 価格分析
  • 特許分析
  • 2024年～2025年の主な会議とイベント
  • ケーススタディ分析
  • 収益モデル分析
  • エンドユーザー分析
  • 資金調達の情勢
  • 貿易分析

第6章 薬剤スクリーニング市場、製品・サービス別

  • イントロダクション
  • 薬剤スクリーニングサービス
  • 薬剤スクリーニング製品

第7章 薬剤スクリーニング市場、サンプルタイプ別

  • イントロダクション
  • 尿サンプル
  • 呼気サンプル
  • 口腔液サンプル
  • 毛髪サンプル
  • その他

第8章 薬剤スクリーニング市場、薬剤タイプ別

  • イントロダクション
  • 大麻
  • アルコール
  • コカイン
  • オピオイド
  • アンフェタミンとメタンフェタミン
  • その他

第9章 薬剤スクリーニング市場、エンドユーザー別

  • イントロダクション
  • 薬剤スクリーニング研究所
  • 職場
  • 刑事司法制度と法執行機関
  • 病院
  • 薬剤治療センター
  • 個人ユーザー
  • 疼痛管理センター
  • 学校と大学
  • その他

第10章 薬剤スクリーニング市場、地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第11章 競合情勢

  • イントロダクション
  • 主要参入企業の戦略/秘策
  • 収益分析
  • 市場シェア分析
  • ブランド/製品比較
  • 企業評価マトリックス：主要参入企業、2023年
  • 企業評価マトリックス：スタートアップ/中小企業、2023年
  • 評価と財務指標
  • 競合シナリオ

第12章 企業プロファイル

  • 主要参入企業
    • LABORATORY CORPORATION OF AMERICA HOLDINGS
    • QUEST DIAGNOSTICS
    • ABBOTT
    • ORASURE TECHNOLOGIES INC.
    • ALFA SCIENTIFIC DESIGNS INC.
    • THERMO FISHER SCIENTIFIC INC.
    • DRAGERWERK AG & CO. KGAA
    • LIFELOC TECHNOLOGIES, INC.
    • MPD INC.
    • OMEGA LABORATORIES, INC.
    • PREMIER BIOTECH, INC.
    • PSYCHEMEDICS CORPORATION
    • F. HOFFMANN-LA ROCHE LTD.
    • SHIMADZU CORPORATION
    • SIEMENS HEALTHINEERS AG
  • その他の企業
    • AMERICAN BIO MEDICA CORPORATION
    • ACM GLOBAL LABORATORIES
    • CAREHEALTH AMERICA CORP.
    • CLINICAL REFERENCE LABORATORY, INC.
    • INTOXIMETERS
    • SCITECK, INC.
    • ACCUSOURCEHR, INC.
    • CORDANT HEALTH SOLUTIONS
    • INTOXALOCK
    • MILLENNIUM HEALTH
    • ADVACARE PHARMA

第13章 付録

目次
Product Code: MD 3239

The global drug screening market is projected to reach USD 19.5 billion by 2029, from USD 9.1 billion in 2024, at a CAGR of 16.6%. Factors such as enforcement of stringent laws mandating drug & alcohol testing, increasing drug & alcohol consumption, growing regulatory approvals for drug screening products & services. However, prohibits on alcohol consumption in Islamic countries and bans on workplace drug testing in particular countries may hamper the growth of this market to a definite extent.

Scope of the Report
Years Considered for the Study2018-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD) Billion
SegmentsProduct & Service, Sample type, Drug Type, End User, and Region
Regions coveredNorth America, Europe, APAC, LATAM, MEA

"Drug screening services are expected to grow at the highest CAGR from 2024-2029".

Drug screening market is divided into drug screening products and drug screening services. The services segment is stated to hold the highest growth rate during the forecast period, factors such increasing drug & alcohol consumption worldwide, geographic expansions of drug & alcohol testing laboratories, funding initiatives for drug testing laboratories, stringent laws regarding drug testing, and increasing approvals for drug tests contribute to the market.

"Analytical instrument segment to dominate the drug screening products market from 2024-2029".

Drug screening products are divided into analytical instruments, rapid testing devices, and consumables. The analytical instruments segment holds for the largest share of the drug screening products market in 2023. Factors such as growing alcohol consumption, rising drunk driving & DUI cases, stringent government laws mandating drug & alcohol testing, and technological advancements in analytical instruments.However, the rapid testing devices market is stated to register the highest growth rate during the forecast period, owing to its constant requirement.

"By region, North America will dominate the market during 2024-2029."

Geographically, the drug screening market is segmented into North America, Europe, the Asia Pacific, and Latin America, Middle East & Africa. In 2023, North America holds for the largest share of the drug screening market followed by Europe. However, Asia Pacific is deemed to register the highest growth rate during the forecast period. The high growth of this regional segment is credited due to the growing illicit consumption of drugs, stricter regulations are being implemented that require more frequent drug testing.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1: 57%, Tier 2: 30%, and Tier 3: 13%
  • By Designation - C-level: 30%, D-level: 45%, and Others: 25%
  • By Region - North America: 40%, Europe: 19%, Asia Pacific: 29%, Latin America: 7% and Middle East and Africa: 5%

Some of the prominent players operating in the drug screening market are Labcorp (US), Quest Diagnostics (US), Abbott (US), Thermo Fisher Scientific Inc. (US), Alfa Scientific Designs, Inc. (US), OraSure Technologies Inc. (US), Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), MPD Inc. (US), Shimadzu Corporation (Japan), Lifeloc Technologies, Inc. (US), Dragerwerk AG & Co. KGaA (Germany), Premier Biotech, Inc. (US), Omega Laboratories, Inc. (US), Psychemedics Corporation (US), Clinical Reference Laboratory, Inc. (US), American Bio Medica Corporation (US), ACM Global Laboratories (US), CareHealth America Corp (US), Sciteck, Inc. (US), Intoximeters, Inc. (US), AccuSourceHR, Inc. (US), Cordant Health Solutions (US), Intoxalock (US), Millennium Health (US).

Research Coverage:

The report dives into the global drug screening market, aiming to assess its current size and predict its future growth. It accomplishes this by segmenting the market based on various factors including product type, service type, sample collection method, end user, and geographical location. By understanding these market segments, the report offers insights into the opportunities available for businesses in this field. Additionally, it analyzes the factors that can influence the market's growth, such as drivers, restraints, and opportunities. It also examines the competitive landscape, providing details on the major players in the market. Lastly, the report forecasts revenue for the market segments across four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: extensive information on drug screening offered by the top 25 players in the drug screening market. The report analyses the drug screening market by product and service, sample type, drug type, end user, and region.
  • Analysis of key drivers (increase in drug abuse and alcohol consumption, enforcement of stringent laws,) restrains (ban on alcohol consumption on Islamic states), challenges (false positive and inaccurate results of breathalyzer), opportunities (oral fluid testing and emerging economies) are contributing the growth of the drug screening market.
  • Market Development: Comprehensive information about economic emerging markets. The report analyses the markets for various drug screening across key geographic regions.
  • Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new product/service launches in the drug screening market.
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the drug screening market.
  • Company profiling: In-depth assessment of company profiling and their market ranking and strategies of the leading players in the drug screening market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 DRUG SCREENING MARKET: MARKETS COVERED
    • 1.3.2 REGIONS COVERED
    • FIGURE 2 DRUG SCREENING MARKET: REGIONS COVERED
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 MARKET STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES
    • 1.5.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 3 DRUG SCREENING MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • FIGURE 4 DRUG SCREENING MARKET: KEY DATA FROM SECONDARY SOURCES
    • 2.1.2 PRIMARY DATA
    • FIGURE 5 DRUG SCREENING MARKET: PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
    • FIGURE 6 DRUG SCREENING MARKET: KEY DATA FROM PRIMARY SOURCES
      • 2.1.2.2 Key industry insights
    • FIGURE 7 DRUG SCREENING MARKET: KEY INDUSTRY INSIGHTS
      • 2.1.2.3 Breakdown of primary interviews
    • FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY, DESIGNATION, AND REGION
    • FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 TOTAL MARKET SIZE ESTIMATION
    • 2.2.2 REVENUE SHARE ANALYSIS
    • FIGURE 10 MARKET SIZE ESTIMATION (SUPPLY SIDE): REVENUE SHARE ANALYSIS
    • 2.2.3 BOTTOM-UP APPROACH
    • FIGURE 11 DRUG SCREENING MARKET: BOTTOM-UP APPROACH
    • 2.2.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
    • 2.2.5 TOP-DOWN APPROACH
    • FIGURE 12 DRUG SCREENING MARKET: TOP-DOWN APPROACH
  • 2.3 MARKET GROWTH FORECAST
    • FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024-2029)
    • FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 15 DATA TRIANGULATION METHODOLOGY
  • 2.5 STUDY ASSUMPTIONS
    • TABLE 1 DRUG SCREENING MARKET: STUDY ASSUMPTIONS
  • 2.6 RISK ASSESSMENT
    • TABLE 2 DRUG SCREENING MARKET: RISK ASSESSMENT
  • 2.7 RESEARCH LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.7.2 SCOPE-RELATED LIMITATIONS
  • 2.8 IMPACT OF ECONOMIC RECESSION ON DRUG SCREENING MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 16 DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD MILLION)
    • FIGURE 17 DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
    • FIGURE 18 DRUG SCREENING MARKET, BY DRUG TYPE, 2024 VS. 2029 (USD MILLION)
    • FIGURE 19 DRUG SCREENING MARKET, BY SAMPLE TYPE, 2024 VS. 2029 (USD MILLION)
    • FIGURE 20 DRUG SCREENING MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
    • FIGURE 21 REGIONAL SEGMENTATION OF DRUG SCREENING MARKET

4 PREMIUM INSIGHTS

  • 4.1 DRUG SCREENING MARKET OVERVIEW
    • FIGURE 22 GROWING CONSUMPTION OF ILLICIT DRUGS AND ALCOHOL TO DRIVE MARKET
  • 4.2 NORTH AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE AND COUNTRY (2023)
    • FIGURE 23 US AND DRUG SCREENING SERVICES TO COMMAND LARGEST MARKET SHARE DURING FORECAST PERIOD
  • 4.3 DRUG SCREENING MARKET: REGIONAL MIX (2022-2029)
    • FIGURE 24 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING STUDY PERIOD
  • 4.4 DRUG SCREENING MARKET: GEOGRAPHICAL SNAPSHOT (2024-2029)
    • FIGURE 25 INDIA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD
  • 4.5 DRUG SCREENING MARKET: DEVELOPED VS. EMERGING ECONOMIES (2024 VS. 2029)
    • FIGURE 26 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 27 DRUG SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing consumption of illicit drugs and alcohol
      • 5.2.1.2 Enforcement of stringent laws mandating drug and alcohol testing
      • 5.2.1.3 Increasing number of regulatory approvals for drug screening products and services
    • TABLE 3 KEY PRODUCT AND SERVICE LAUNCHES FOR DRUG AND ALCOHOL TESTING, 2020-2022
    • TABLE 4 LIST OF REGULATORY AUTHORITIES FOR DRUG AND ALCOHOL TESTING PRODUCTS AND SERVICES
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Ban on alcohol consumption in Islamic countries
      • 5.2.2.2 Prohibition on workplace drug testing
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Popularity of oral fluid testing
      • 5.2.3.2 Introduction of fingerprint-based drug testing at workplaces
      • 5.2.3.3 High growth opportunities in emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Accuracy and specificity concerns in breathalyzers
      • 5.2.4.2 False positive and negative results in drug screening
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 28 SHIFTS AND NEW REVENUE POCKETS FOR DRUG SCREENING MARKET
  • 5.4 INDUSTRY TRENDS
    • 5.4.1 INCREASING USE OF ORAL FLUID TESTING
    • 5.4.2 GROWING NEED FOR SUBSTANCE TESTING PANELS
    • 5.4.3 TECHNOLOGICAL ADVANCEMENTS
    • 5.4.4 RISING FOCUS ON EMPLOYEE WELLNESS
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 29 DRUG SCREENING MARKET: VALUE CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS
    • FIGURE 30 DRUG SCREENING MARKET: ECOSYSTEM MAP
    • TABLE 5 DRUG SCREENING MARKET: ROLE IN ECOSYSTEM
  • 5.7 TECHNOLOGY ANALYSIS
    • 5.7.1 KEY TECHNOLOGIES
      • 5.7.1.1 Sweat patch testing
      • 5.7.1.2 Alcohol ignition interlock device
      • 5.7.1.3 Point-of-care testing
    • 5.7.2 COMPLEMENTARY TECHNOLOGIES
      • 5.7.2.1 Artificial Intelligence and machine learning
      • 5.7.2.2 Biosensors
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 31 DRUG SCREENING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • TABLE 6 DRUG SCREENING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.8.2 BARGAINING POWER OF SUPPLIERS
    • 5.8.3 BARGAINING POWER OF BUYERS
    • 5.8.4 THREAT OF SUBSTITUTES
    • 5.8.5 THREAT OF NEW ENTRANTS
  • 5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 32 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
    • TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
    • 5.9.2 KEY BUYING CRITERIA
    • FIGURE 33 KEY BUYING CRITERIA FOR TOP THREE END USERS
    • TABLE 8 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • 5.10 TARIFF AND REGULATORY ANALYSIS
    • 5.10.1 TARIFF ANALYSIS
      • 5.10.1.1 Tariff of chromatography instruments (HS code: 902720)
    • TABLE 9 TARIFF FOR CHROMATOGRAPHY INSTRUMENTS (HS CODE: 902720)
    • 5.10.2 REGULATORY ANALYSIS
      • 5.10.2.1 North America
        • 5.10.2.1.1 US
    • TABLE 10 US: DRUG AND ALCOHOL TESTING REGULATIONS
      • 5.10.2.2 Europe
        • 5.10.2.2.1 Finland
        • 5.10.2.2.2 Sweden
        • 5.10.2.2.3 France
        • 5.10.2.2.4 Italy
        • 5.10.2.2.5 UK
        • 5.10.2.2.6 Netherlands
        • 5.10.2.2.7 Ireland
      • 5.10.2.3 Asia Pacific
        • 5.10.2.3.1 Japan
        • 5.10.2.3.2 China
        • 5.10.2.3.3 India
      • 5.10.2.4 Australia and New Zealand
      • 5.10.2.5 Latin America
      • 5.10.2.6 Middle East & Africa
    • 5.10.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.11 PRICING ANALYSIS
    • 5.11.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
    • FIGURE 34 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
    • TABLE 16 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
    • 5.11.2 INDICATIVE PRICING ANALYSIS
  • 5.12 PATENT ANALYSIS
    • 5.12.1 PATENT PUBLICATION TRENDS FOR DRUG SCREENING PRODUCTS
    • FIGURE 35 PATENT PUBLICATION TRENDS IN DRUG SCREENING MARKET (JANUARY 2012-DECEMBER 2023)
    • 5.12.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    • FIGURE 36 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR DRUG SCREENING PATENTS (JANUARY 2012-NOVEMBER 2023)
    • FIGURE 37 TOP APPLICANT COUNTRIES/REGIONS FOR DRUG SCREENING PATENTS (JANUARY 2012-DECEMBER 2023)
    • TABLE 17 DRUG SCREENING MARKET: LIST OF MAJOR PATENTS
  • 5.13 KEY CONFERENCES AND EVENTS IN 2024-2025
    • TABLE 18 DRUG SCREENING MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS
  • 5.14 CASE STUDY ANALYSIS
    • 5.14.1 LEADING RETAIL CHAIN TO SAVE USD 1 MILLION WITH INSTANT ORAL FLUID DRUG SCREENING SOLUTIONS
    • 5.14.2 PRE-EMPLOYMENT TESTING IN LONG-TERM CARE INDUSTRY
    • 5.14.3 USE OF HAIR TESTING AND URINALYSIS IN TRANSPORTATION INDUSTRY
    • 5.14.4 RANDOM TESTING IN MANUFACTURING AND AUTOMOTIVE INDUSTRIES
  • 5.15 REVENUE MODEL ANALYSIS
    • 5.15.1 SERVICE FEES
    • 5.15.2 PRODUCT SALES
    • 5.15.3 SERVICE PACKAGES
  • 5.16 END USER ANALYSIS
    • 5.16.1 UNMET NEEDS
    • TABLE 19 UNMET NEEDS IN DRUG SCREENING MARKET
    • 5.16.2 END USER EXPECTATIONS
    • TABLE 20 END USER EXPECTATIONS IN DRUG SCREENING MARKET
  • 5.17 FUNDING LANDSCAPE
    • FIGURE 38 FUNDING OF KEY PLAYERS IN DRUG SCREENING MARKET
  • 5.18 TRADE ANALYSIS
    • FIGURE 39 IMPORT DATA FOR CHROMATOGRAPHY (HS CODE 902720), BY COUNTRY, 2019-2023 (USD)
    • FIGURE 40 EXPORT DATA FOR CHROMATOGRAPHY (HS CODE 902720), BY COUNTRY, 2019-2023 (USD MILLION)

6 DRUG SCREENING MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 21 DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 22 DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
  • 6.2 DRUG SCREENING SERVICES
    • TABLE 23 DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 24 DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 25 DRUG SCREENING SERVICES MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 26 DRUG SCREENING SERVICES MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.2.1 LABORATORY TESTING SERVICES
      • 6.2.1.1 Higher accuracy and better reliability to propel segment growth
    • TABLE 27 LABORATORY TESTING SERVICES MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 28 LABORATORY TESTING SERVICES MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.2.2 ON-SITE TESTING SERVICES
      • 6.2.2.1 Increasing emphasis on workplace safety to drive market
    • TABLE 29 ON-SITE TESTING SERVICES MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 30 ON-SITE TESTING SERVICES MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
  • 6.3 DRUG SCREENING PRODUCTS
    • TABLE 31 DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 32 DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 33 DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 34 DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.1 ANALYTICAL INSTRUMENTS
      • 6.3.1.1 Analytical instruments market, by type
    • TABLE 35 ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 36 ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 37 ANALYTICAL INSTRUMENT TYPES MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 38 ANALYTICAL INSTRUMENT TYPES MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
        • 6.3.1.1.1 Breathalyzers
    • TABLE 39 BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 40 BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 41 BREATHALYZERS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 42 BREATHALYZERS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
          • 6.3.1.1.1.1 Fuel-cell breathalyzers
  • 6.3.1.1.1.1.1 High accuracy, sensitivity, and reliability to support segment growth
    • TABLE 43 FUEL-CELL BREATHALYZERS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 44 FUEL-CELL BREATHALYZERS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
          • 6.3.1.1.1.2 Semiconductor breathalyzers
  • 6.3.1.1.1.2.1 Low cost and high accuracy to aid segment growth
    • TABLE 45 SEMICONDUCTOR BREATHALYZERS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 46 SEMICONDUCTOR BREATHALYZERS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
          • 6.3.1.1.1.3 Other breathalyzers
    • TABLE 47 OTHER BREATHALYZERS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 48 OTHER BREATHALYZERS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
        • 6.3.1.1.2 Immunoassay analyzers
          • 6.3.1.1.2.1 Technological advancements and high demand for drug testing to drive segment
    • TABLE 49 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 50 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
        • 6.3.1.1.3 Chromatography instruments
          • 6.3.1.1.3.1 More flexibility and higher accuracy to fuel segment growth
    • TABLE 51 CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 52 CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
      • 6.3.1.2 Analytical instruments market, by modality
    • TABLE 53 ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 54 ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 55 ANALYTICAL INSTRUMENT MODALITIES MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 56 ANALYTICAL INSTRUMENT MODALITIES MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
        • 6.3.1.2.1 Hand-held drug screening products
          • 6.3.1.2.1.1 Rising need for quick alcohol intoxication level assessment to drive segment
    • TABLE 57 HAND-HELD DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 58 HAND-HELD DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
        • 6.3.1.2.2 Benchtop drug screening products
          • 6.3.1.2.2.1 High sensitivity and specificity to different drugs at low concentrations to boost segment growth
    • TABLE 59 BENCHTOP DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 60 BENCHTOP DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.2 RAPID TESTING DEVICES
    • TABLE 61 RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 62 RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 63 RAPID TESTING DEVICES MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 64 RAPID TESTING DEVICES MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
      • 6.3.2.1 Urine testing devices
    • TABLE 65 URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 66 URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 67 URINE TESTING DEVICES MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 68 URINE TESTING DEVICES MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
        • 6.3.2.1.1 Drug testing cups
          • 6.3.2.1.1.1 Reduced chances of sample contamination to drive segment
    • TABLE 69 DRUG TESTING CUPS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 70 DRUG TESTING CUPS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
        • 6.3.2.1.2 Dip cards
          • 6.3.2.1.2.1 No instrument requirements during urine testing to boost segment growth
    • TABLE 71 DIP CARDS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 72 DIP CARDS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
        • 6.3.2.1.3 Drug testing cassettes
          • 6.3.2.1.3.1 Cost-effectiveness and quick results to augment segment growth
    • TABLE 73 DRUG TESTING CASSETTES MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 74 DRUG TESTING CASSETTES MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
      • 6.3.2.2 Oral fluid testing devices
        • 6.3.2.2.1 Low possibility of sample tampering to aid market growth
    • TABLE 75 ORAL FLUID TESTING DEVICES MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 76 ORAL FLUID TESTING DEVICES MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • 6.3.3 CONSUMABLES
    • TABLE 77 CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 78 CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 79 CONSUMABLES MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 80 CONSUMABLES MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
      • 6.3.3.1 Assay kits
        • 6.3.3.1.1 Increased focus on rapid, inexpensive, and convenient sample screening methods to drive market
    • TABLE 81 ASSAY KITS MARKET, BY COUNTRY 2018-2022 (USD MILLION)
    • TABLE 82 ASSAY KITS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
      • 6.3.3.2 Sample collection devices
        • 6.3.3.2.1 Rising need for safe and efficient sample collection and transportation to propel market growth
    • TABLE 83 SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 84 SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
      • 6.3.3.3 Calibrators and controls
        • 6.3.3.3.1 Growing need for quantitative comparison with actual test samples to fuel market growth
    • TABLE 85 CALIBRATORS AND CONTROLS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 86 CALIBRATORS AND CONTROLS MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
      • 6.3.3.4 Other consumables
    • TABLE 87 OTHER CONSUMABLES MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 88 OTHER CONSUMABLES MARKET, BY COUNTRY, 2023-2029 (USD MILLION)

7 DRUG SCREENING MARKET, BY SAMPLE TYPE

  • 7.1 INTRODUCTION
    • TABLE 89 DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 90 DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
  • 7.2 URINE SAMPLES
    • 7.2.1 EASE OF COLLECTION AND COST-EFFECTIVENESS TO SUPPORT MARKET GROWTH
    • TABLE 91 DRUG SCREENING MARKET FOR URINE SAMPLES, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 92 DRUG SCREENING MARKET FOR URINE SAMPLES, BY COUNTRY, 2023-2029 (USD MILLION)
  • 7.3 BREATH SAMPLES
    • 7.3.1 RISING NUMBER OF DRIVING-UNDER-INFLUENCE CASES TO PROPEL MARKET GROWTH
    • TABLE 93 DRUG SCREENING MARKET FOR BREATH SAMPLES, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 94 DRUG SCREENING MARKET FOR BREATH SAMPLES, BY COUNTRY, 2023-2029 (USD MILLION)
  • 7.4 ORAL FLUID SAMPLES
    • 7.4.1 NON-INVASIVE SAMPLE COLLECTION AND LOW CHANCE OF ADULTERATION TO BOOST MARKET GROWTH
    • TABLE 95 DRUG SCREENING MARKET FOR ORAL FLUID SAMPLES, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 96 DRUG SCREENING MARKET FOR ORAL FLUID SAMPLES, BY COUNTRY, 2023-2029 (USD MILLION)
  • 7.5 HAIR SAMPLES
    • 7.5.1 DETAILED INSIGHTS INTO LONG-TERM DRUG USE TO SPUR MARKET GROWTH
    • TABLE 97 DRUG SCREENING MARKET FOR HAIR SAMPLES, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 98 DRUG SCREENING MARKET FOR HAIR SAMPLES, BY COUNTRY, 2023-2029 (USD MILLION)
  • 7.6 OTHER SAMPLES
    • TABLE 99 DRUG SCREENING MARKET FOR OTHER SAMPLES, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 100 DRUG SCREENING MARKET FOR OTHER SAMPLES, BY COUNTRY, 2023-2029 (USD MILLION)

8 DRUG SCREENING MARKET, BY DRUG TYPE

  • 8.1 INTRODUCTION
    • TABLE 101 DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 102 DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
  • 8.2 CANNABIS
    • 8.2.1 INCREASING LEGALIZATION FOR MEDICAL AND RECREATIONAL PURPOSES TO DRIVE MARKET
    • TABLE 103 DRUG SCREENING MARKET FOR CANNABIS, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 104 DRUG SCREENING MARKET FOR CANNABIS, BY COUNTRY, 2023-2029 (USD MILLION)
  • 8.3 ALCOHOL
    • 8.3.1 RISING REGULATORY COMPLIANCE IN SAFETY-SENSITIVE INDUSTRIES TO DRIVE MARKET
    • TABLE 105 DRUG SCREENING MARKET FOR ALCOHOL, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 106 DRUG SCREENING MARKET FOR ALCOHOL, BY COUNTRY, 2023-2029 (USD MILLION)
  • 8.4 COCAINE
    • 8.4.1 ILLICIT NATURE AND ASSOCIATED HEALTH RISKS TO FUEL MARKET GROWTH
    • TABLE 107 DRUG SCREENING MARKET FOR COCAINE, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 108 DRUG SCREENING MARKET FOR COCAINE, BY COUNTRY, 2023-2029 (USD MILLION)
  • 8.5 OPIOIDS
    • 8.5.1 INCREASING CASES OF OPIOIDS ADDICTION TO AID MARKET GROWTH
    • TABLE 109 DRUG SCREENING MARKET FOR OPIOIDS, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 110 DRUG SCREENING MARKET FOR OPIOIDS, BY COUNTRY, 2023-2029 (USD MILLION)
  • 8.6 AMPHETAMINE AND METHAMPHETAMINE
    • 8.6.1 GROWING USE AMONG EDUCATION SERVICE EMPLOYEES TO AUGMENT MARKET GROWTH
    • TABLE 111 DRUG SCREENING MARKET FOR AMPHETAMINE AND METHAMPHETAMINE, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 112 DRUG SCREENING MARKET FOR AMPHETAMINE AND METHAMPHETAMINE, BY COUNTRY, 2023-2029 (USD MILLION)
  • 8.7 OTHER DRUGS
    • TABLE 113 DRUG SCREENING MARKET FOR OTHER DRUGS, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 114 DRUG SCREENING MARKET FOR OTHER DRUGS, BY COUNTRY, 2023-2029 (USD MILLION)

9 DRUG SCREENING MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 115 DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 116 DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 9.2 DRUG TESTING LABORATORIES
    • 9.2.1 DRUG TESTING LABORATORIES TO COMMAND HIGHEST GROWTH RATE DURING STUDY PERIOD
    • TABLE 117 DRUG SCREENING MARKET FOR DRUG TESTING LABORATORIES, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 118 DRUG SCREENING MARKET FOR DRUG TESTING LABORATORIES, BY COUNTRY, 2023-2029 (USD MILLION)
  • 9.3 WORKPLACES
    • 9.3.1 INCREASED FOCUS ON RANDOM DRUG TESTING AT OFFICES TO FUEL MARKET GROWTH
    • TABLE 119 DRUG SCREENING MARKET FOR WORKPLACES, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 120 DRUG SCREENING MARKET FOR WORKPLACES, BY COUNTRY, 2023-2029 (USD MILLION)
  • 9.4 CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES
    • 9.4.1 GROWING GOVERNMENT FOCUS ON DRUG TESTING TO DRIVE MARKET
    • TABLE 121 DRUG SCREENING MARKET FOR CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 122 DRUG SCREENING MARKET FOR CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2023-2029 (USD MILLION)
  • 9.5 HOSPITALS
    • 9.5.1 RISING DRUG ABUSE CASES TO AID MARKET GROWTH
    • TABLE 123 DRUG SCREENING MARKET FOR HOSPITALS, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 124 DRUG SCREENING MARKET FOR HOSPITALS, BY COUNTRY, 2023-2029 (USD MILLION)
  • 9.6 DRUG TREATMENT CENTERS
    • 9.6.1 GROWING GOVERNMENT SUPPORT AGAINST DRUG ABUSE TO DRIVE MARKET
    • TABLE 125 DRUG SCREENING MARKET FOR DRUG TREATMENT CENTERS, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 126 DRUG SCREENING MARKET FOR DRUG TREATMENT CENTERS, BY COUNTRY, 2023-2029 (USD MILLION)
  • 9.7 INDIVIDUAL USERS
    • 9.7.1 STRINGENT REGULATIONS AND PERSONAL SAFETY CONCERNS TO DRIVE MARKET
    • TABLE 127 DRUG SCREENING MARKET FOR INDIVIDUAL USERS, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 128 DRUG SCREENING MARKET FOR INDIVIDUAL USERS, BY COUNTRY, 2023-2029 (USD MILLION)
  • 9.8 PAIN MANAGEMENT CENTERS
    • 9.8.1 GROWING ABUSE OF PRESCRIPTION DRUGS TO DRIVE MARKET
    • TABLE 129 DRUG SCREENING MARKET FOR PAIN MANAGEMENT CENTERS, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 130 DRUG SCREENING MARKET FOR PAIN MANAGEMENT CENTERS, BY COUNTRY, 2023-2029 (USD MILLION)
  • 9.9 SCHOOLS AND COLLEGES
    • 9.9.1 RISING FOCUS ON DRUG ABUSE TESTING PROGRAMS TO SUPPORT MARKET GROWTH
    • TABLE 131 DRUG SCREENING MARKET FOR SCHOOLS AND COLLEGES, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 132 DRUG SCREENING MARKET FOR SCHOOLS AND COLLEGES, BY COUNTRY, 2023-2029 (USD MILLION)
  • 9.10 OTHER END USERS
    • TABLE 133 DRUG SCREENING MARKET FOR OTHER END USERS, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 134 DRUG SCREENING MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2029 (USD MILLION)

10 DRUG SCREENING MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 135 DRUG SCREENING MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 136 DRUG SCREENING MARKET, BY REGION, 2023-2029 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 41 NORTH AMERICA: DRUG SCREENING MARKET SNAPSHOT
    • TABLE 137 NORTH AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 138 NORTH AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • TABLE 139 NORTH AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 140 NORTH AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 141 NORTH AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 142 NORTH AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 143 NORTH AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 144 NORTH AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 145 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 146 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 147 NORTH AMERICA: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 148 NORTH AMERICA: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 149 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 150 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 151 NORTH AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 152 NORTH AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 153 NORTH AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 154 NORTH AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 155 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 156 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 157 NORTH AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 158 NORTH AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 159 NORTH AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 160 NORTH AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 161 NORTH AMERICA: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 162 NORTH AMERICA: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
    • 10.2.1 NORTH AMERICA: RECESSION IMPACT
    • 10.2.2 US
      • 10.2.2.1 US to dominate North American drug screening market during study period
    • TABLE 163 US: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 164 US: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 165 US: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 166 US: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 167 US: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 168 US: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 169 US: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 170 US: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 171 US: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 172 US: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 173 US: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 174 US: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 175 US: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 176 US: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 177 US: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 178 US: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 179 US: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 180 US: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 181 US: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 182 US: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 183 US: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 184 US: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 185 US: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 186 US: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
    • 10.2.3 CANADA
      • 10.2.3.1 Increasing drunk driving-related accidental deaths to support market growth
    • TABLE 187 CANADA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 188 CANADA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 189 CANADA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 190 CANADA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 191 CANADA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 192 CANADA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 193 CANADA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 194 CANADA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 195 CANADA: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 196 CANADA: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 197 CANADA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 198 CANADA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 199 CANADA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 200 CANADA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 201 CANADA: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 202 CANADA: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 203 CANADA: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 204 CANADA: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 205 CANADA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 206 CANADA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 207 CANADA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 208 CANADA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 209 CANADA: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 210 CANADA: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 211 EUROPE: DRUG SCREENING MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 212 EUROPE: DRUG SCREENING MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • TABLE 213 EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 214 EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 215 EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 216 EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 217 EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 218 EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 219 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 220 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 221 EUROPE: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 222 EUROPE: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 223 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 224 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 225 EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 226 EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 227 EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 228 EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 229 EUROPE: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 230 EUROPE: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 231 EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 232 EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 233 EUROPE: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 234 EUROPE: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 235 EUROPE: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 236 EUROPE: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
    • 10.3.1 EUROPE: RECESSION IMPACT
    • 10.3.2 GERMANY
      • 10.3.2.1 Increasing number of drug-related deaths to drive market
    • TABLE 237 GERMANY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 238 GERMANY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 239 GERMANY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 240 GERMANY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 241 GERMANY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 242 GERMANY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 243 GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 244 GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 245 GERMANY: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 246 GERMANY: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 247 GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 248 GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 249 GERMANY: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 250 GERMANY: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 251 GERMANY: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 252 GERMANY: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 253 GERMANY: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 254 GERMANY: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 255 GERMANY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 256 GERMANY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 257 GERMANY: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 258 GERMANY: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 259 GERMANY: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 260 GERMANY: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Robust healthcare infrastructure and proactive approach toward public health to aid market growth
    • TABLE 261 FRANCE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 262 FRANCE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 263 FRANCE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 264 FRANCE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 265 FRANCE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 266 FRANCE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 267 FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 268 FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 269 FRANCE: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 270 FRANCE: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 271 FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 272 FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 273 FRANCE: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 274 FRANCE: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 275 FRANCE: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 276 FRANCE: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 277 FRANCE: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 278 FRANCE: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 279 FRANCE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 280 FRANCE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 281 FRANCE: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 282 FRANCE: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 283 FRANCE: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 284 FRANCE: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
    • 10.3.4 UK
      • 10.3.4.1 Increase in illicit drug consumption to augment market growth
    • TABLE 285 UK: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 286 UK: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 287 UK: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 288 UK: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 289 UK: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 290 UK: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 291 UK: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 292 UK: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 293 UK: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 294 UK: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 295 UK: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 296 UK: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 297 UK: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 298 UK: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 299 UK: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 300 UK: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 301 UK: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 302 UK: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 303 UK: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 304 UK: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 305 UK: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 306 UK: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 307 UK: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 308 UK: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
    • 10.3.5 ITALY
      • 10.3.5.1 Growing consumption of illegal psychoactive substances and drugs among minors to boost market growth
    • TABLE 309 ITALY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 310 ITALY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 311 ITALY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 312 ITALY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 313 ITALY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 314 ITALY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 315 ITALY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 316 ITALY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 317 ITALY: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 318 ITALY: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 319 ITALY: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 320 ITALY: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 321 ITALY: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 322 ITALY: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 323 ITALY: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 324 ITALY: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 325 ITALY: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 326 ITALY: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 327 ITALY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 328 ITALY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 329 ITALY: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 330 ITALY: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 331 ITALY: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 332 ITALY: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
    • 10.3.6 SPAIN
      • 10.3.6.1 Stringent government regulations and high consumption of alcohol to aid market growth
    • TABLE 333 SPAIN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 334 SPAIN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 335 SPAIN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 336 SPAIN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 337 SPAIN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 338 SPAIN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 339 SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 340 SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 341 SPAIN: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 342 SPAIN: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 343 SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 344 SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 345 SPAIN: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 346 SPAIN: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 347 SPAIN: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 348 SPAIN: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 349 SPAIN: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 350 SPAIN: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 351 SPAIN: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 352 SPAIN: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 353 SPAIN: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 354 SPAIN: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 355 SPAIN: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 356 SPAIN: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
    • 10.3.7 REST OF EUROPE
    • TABLE 357 REST OF EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 358 REST OF EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 359 REST OF EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 360 REST OF EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 361 REST OF EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 362 REST OF EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 363 REST OF EUROPE: ANALYTICAL INSTRUMENTS MARKET, 2018-2022 (USD MILLION)
    • TABLE 364 REST OF EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 365 REST OF EUROPE: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 366 REST OF EUROPE: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 367 REST OF EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 368 REST OF EUROPE ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 369 REST OF EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 370 REST OF EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 371 REST OF EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 372 REST OF EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 373 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 374 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 375 REST OF EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 376 REST OF EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 377 REST OF EUROPE: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 378 REST OF EUROPE: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 379 REST OF EUROPE: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 380 REST OF EUROPE: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 42 ASIA PACIFIC: DRUG SCREENING MARKET SNAPSHOT
    • TABLE 381 ASIA PACIFIC: DRUG SCREENING MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 382 ASIA PACIFIC: DRUG SCREENING MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • TABLE 383 ASIA PACIFIC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 384 ASIA PACIFIC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 385 ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 386 ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 387 ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 388 ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 389 ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 390 ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 391 ASIA PACIFIC: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 392 ASIA PACIFIC: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 393 ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 394 ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 395 ASIA PACIFIC: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 396 ASIA PACIFIC: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 397 ASIA PACIFIC: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 398 ASIA PACIFIC: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 399 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 400 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 401 ASIA PACIFIC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 402 ASIA PACIFIC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 403 ASIA PACIFIC: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 404 ASIA PACIFIC: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 405 ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 406 ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
    • 10.4.1 ASIA PACIFIC: RECESSION IMPACT
    • 10.4.2 JAPAN
      • 10.4.2.1 Stringent laws for drug abuse and increased government support to drive market
    • TABLE 407 JAPAN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 408 JAPAN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 409 JAPAN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 410 JAPAN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 411 JAPAN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 412 JAPAN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 413 JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 414 JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 415 JAPAN: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 416 JAPAN: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 417 JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 418 JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 419 JAPAN: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 420 JAPAN: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 421 JAPAN: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 422 JAPAN: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 423 JAPAN: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 424 JAPAN: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 425 JAPAN: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 426 JAPAN: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 427 JAPAN: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 428 JAPAN: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 429 JAPAN: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 430 JAPAN: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
    • 10.4.3 CHINA
      • 10.4.3.1 Increasing alcohol consumption and rising cases of drunk driving to fuel market growth
    • TABLE 431 CHINA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 432 CHINA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 433 CHINA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 434 CHINA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 435 CHINA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 436 CHINA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 437 CHINA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 438 CHINA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 439 CHINA: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 440 CHINA: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 441 CHINA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 442 CHINA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 443 CHINA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 444 CHINA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 445 CHINA: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 446 CHINA: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 447 CHINA: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 448 CHINA: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 449 CHINA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 450 CHINA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 451 CHINA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 452 CHINA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 453 CHINA: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 454 CHINA: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
    • 10.4.4 INDIA
      • 10.4.4.1 Increase in illicit drug users and improved healthcare infrastructure to support market growth
    • TABLE 455 INDIA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 456 INDIA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 457 INDIA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 458 INDIA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 459 INDIA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 460 INDIA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 461 INDIA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 462 INDIA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 463 INDIA: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 464 INDIA: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 465 INDIA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 466 INDIA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 467 INDIA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 468 INDIA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 469 INDIA: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 470 INDIA: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 471 INDIA: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 472 INDIA: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 473 INDIA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 474 INDIA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 475 INDIA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 476 INDIA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 477 INDIA: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 478 INDIA: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
    • 10.4.5 REST OF ASIA PACIFIC
    • TABLE 479 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 480 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 481 REST OF ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 482 REST OF ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 483 REST OF ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 484 REST OF ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 485 REST OF ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 486 REST OF ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 487 REST OF ASIA PACIFIC: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 488 REST OF ASIA PACIFIC: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 489 REST OF ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 490 REST OF ASIA PACIFIC ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 491 REST OF ASIA PACIFIC: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 492 REST OF ASIA PACIFIC: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 493 REST OF ASIA PACIFIC: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 494 REST OF ASIA PACIFIC: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 495 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 496 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 497 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 498 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 499 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 500 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 501 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 502 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 10.5 LATIN AMERICA
    • TABLE 503 LATIN AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 504 LATIN AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2023-2029 (USD MILLION)
    • TABLE 505 LATIN AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 506 LATIN AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 507 LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 508 LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 509 LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 510 LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 511 LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 512 LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 513 LATIN AMERICA: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 514 LATIN AMERICA: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 515 LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 516 LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 517 LATIN AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 518 LATIN AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 519 LATIN AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 520 LATIN AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 521 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 522 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 523 LATIN AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 524 LATIN AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 525 LATIN AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 526 LATIN AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 527 LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 528 LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
    • 10.5.1 LATIN AMERICA: RECESSION IMPACT
    • 10.5.2 BRAZIL
      • 10.5.2.1 Growing emphasis on substance abuse prevention at workplaces to drive market
    • TABLE 529 BRAZIL: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 530 BRAZIL: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 531 BRAZIL: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 532 BRAZIL: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 533 BRAZIL: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 534 BRAZIL: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 535 BRAZIL: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 536 BRAZIL: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 537 BRAZIL: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 538 BRAZIL: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 539 BRAZIL: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 540 BRAZIL: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 541 BRAZIL: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 542 BRAZIL: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 543 BRAZIL: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 544 BRAZIL: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 545 BRAZIL: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 546 BRAZIL: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 547 BRAZIL: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 548 BRAZIL: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 549 BRAZIL: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 550 BRAZIL: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 551 BRAZIL: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 552 BRAZIL: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
    • 10.5.3 MEXICO
      • 10.5.3.1 Increasing government focus on controlling drug trafficking and substance abuse to propel market growth
    • TABLE 553 MEXICO: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 554 MEXICO: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 555 MEXICO: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 556 MEXICO: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 557 MEXICO: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 558 MEXICO: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 559 MEXICO: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 560 MEXICO: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 561 MEXICO: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 562 MEXICO: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 563 MEXICO: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 564 MEXICO: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 565 MEXICO: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 566 MEXICO: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 567 MEXICO: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 568 MEXICO: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 569 MEXICO: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 570 MEXICO: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 571 MEXICO: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 572 MEXICO: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 573 MEXICO: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 574 MEXICO: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 575 MEXICO: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 576 MEXICO: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
    • 10.5.4 REST OF LATIN AMERICA
    • TABLE 577 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 578 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 579 REST OF LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 580 REST OF LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 581 REST OF LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 582 REST OF LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 583 REST OF LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 584 REST OF LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 585 REST OF LATIN AMERICA: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 586 REST OF LATIN AMERICA: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 587 REST OF LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 588 REST OF LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 589 REST OF LATIN AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 590 REST OF LATIN AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 591 REST OF LATIN AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 592 REST OF LATIN AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 593 REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 594 REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 595 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 596 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 597 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 598 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 599 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 600 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • TABLE 601 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 602 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY REGION, 2023-2029 (USD MILLION)
    • TABLE 603 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 604 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 605 MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 606 MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 607 MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 608 MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 609 MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 610 MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 611 MIDDLE EAST & AFRICA: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 612 MIDDLE EAST & AFRICA: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 613 MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 614 MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 615 MIDDLE EAST & AFRICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 616 MIDDLE EAST & AFRICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 617 MIDDLE EAST & AFRICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 618 MIDDLE EAST & AFRICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 619 MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 620 MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 621 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 622 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 623 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 624 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 625 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 626 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
    • 10.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
    • 10.6.2 GCC COUNTRIES
      • 10.6.2.1 Technological advancements in drug screening to drive market
    • TABLE 627 GCC COUNTRIES: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 628 GCC COUNTRIES: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 629 GCC COUNTRIES: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 630 GCC COUNTRIES: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 631 GCC COUNTRIES: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 632 GCC COUNTRIES: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 633 GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 634 GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 635 GCC COUNTRIES: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 636 GCC COUNTRIES: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 637 GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 638 GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 639 GCC COUNTRIES: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 640 GCC COUNTRIES: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 641 GCC COUNTRIES: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 642 GCC COUNTRIES: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 643 GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 644 GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 645 GCC COUNTRIES: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 646 GCC COUNTRIES: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 647 GCC COUNTRIES: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 648 GCC COUNTRIES: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 649 GCC COUNTRIES: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 650 GCC COUNTRIES: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)
    • 10.6.3 REST OF MIDDLE EAST & AFRICA
    • TABLE 651 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION)
    • TABLE 652 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION)
    • TABLE 653 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 654 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 655 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 656 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 657 REST OF MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 658 REST OF MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 659 REST OF MIDDLE EAST & AFRICA: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 660 REST OF MIDDLE EAST & AFRICA: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 661 REST OF MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION)
    • TABLE 662 REST OF MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION)
    • TABLE 663 REST OF MIDDLE EAST & AFRICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 664 REST OF MIDDLE EAST & AFRICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 665 REST OF MIDDLE EAST & AFRICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 666 REST OF MIDDLE EAST & AFRICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 667 REST OF MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 668 REST OF MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION)
    • TABLE 669 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION)
    • TABLE 670 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION)
    • TABLE 671 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION)
    • TABLE 672 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION)
    • TABLE 673 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION)
    • TABLE 674 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    • FIGURE 43 DRUG SCREENING MARKET: STRATEGIES ADOPTED
  • 11.3 REVENUE ANALYSIS
    • FIGURE 44 DRUG SCREENING MARKET: REVENUE ANALYSIS (2019-2023)
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 45 DRUG SCREENING MARKET: MARKET SHARE ANALYSIS (2023)
    • TABLE 675 DRUG SCREENING MARKET: DEGREE OF COMPETITION
    • 11.4.1 MARKET RANKING ANALYSIS
    • FIGURE 46 DRUG SCREENING MARKET RANKING, BY KEY PLAYER (2023)
      • 11.4.1.1 Laboratory Corporation of America Holdings
      • 11.4.1.2 Quest Diagnostics
      • 11.4.1.3 Abbott
  • 11.5 BRAND/PRODUCT COMPARISON
    • FIGURE 47 DRUG SCREENING MARKET: BRAND/PRODUCT COMPARISON
  • 11.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.6.1 STARS
    • 11.6.2 EMERGING LEADERS
    • 11.6.3 PERVASIVE PLAYERS
    • 11.6.4 PARTICIPANTS
    • FIGURE 48 DRUG SCREENING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
    • 11.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.6.5.1 Overall footprint
    • TABLE 676 DRUG SCREENING MARKET: OVERALL FOOTPRINT
      • 11.6.5.2 Product footprint
    • TABLE 677 DRUG SCREENING MARKET: PRODUCT FOOTPRINT
      • 11.6.5.3 Service footprint
    • TABLE 678 DRUG SCREENING MARKET: SERVICE FOOTPRINT
      • 11.6.5.4 Sample type footprint
    • TABLE 679 DRUG SCREENING MARKET: SAMPLE TYPE FOOTPRINT
      • 11.6.5.5 Drug type footprint
    • TABLE 680 DRUG SCREENING MARKET: DRUG TYPE FOOTPRINT
      • 11.6.5.6 Regional footprint
    • TABLE 681 DRUG SCREENING MARKET: REGIONAL FOOTPRINT
  • 11.7 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
    • 11.7.1 PROGRESSIVE COMPANIES
    • 11.7.2 RESPONSIVE COMPANIES
    • 11.7.3 DYNAMIC COMPANIES
    • 11.7.4 STARTING BLOCKS
    • FIGURE 49 DRUG SCREENING MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
    • 11.7.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
    • TABLE 682 DRUG SCREENING MARKET: DETAILED LIST OF KEY START-UPS/SMES
    • TABLE 683 DRUG SCREENING MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
  • 11.8 VALUATION AND FINANCIAL METRICS
    • FIGURE 50 EV/EBITDA OF KEY VENDORS
    • FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT/SERVICE LAUNCHES AND DEVELOPMENTS
    • TABLE 684 DRUG SCREENING MARKET: PRODUCT/SERVICE LAUNCHES AND DEVELOPMENTS, JANUARY 2021-APRIL 2024
    • 11.9.2 DEALS
    • TABLE 685 DRUG SCREENING MARKET: DEALS, JANUARY 2021-APRIL 2024
    • 11.9.3 OTHER DEVELOPMENTS
    • TABLE 686 DRUG SCREENING MARKET: OTHER DEVELOPMENTS, JANUARY 2021-APRIL 2024

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 12.1.1 LABORATORY CORPORATION OF AMERICA HOLDINGS
    • TABLE 687 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW
    • FIGURE 52 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2023)
    • TABLE 688 LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 689 LABORATORY CORPORATION OF AMERICA HOLDINGS: DEALS
    • 12.1.2 QUEST DIAGNOSTICS
    • TABLE 690 QUEST DIAGNOSTICS: COMPANY OVERVIEW
    • FIGURE 53 QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2023)
    • TABLE 691 QUEST DIAGNOSTICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 692 QUEST DIAGNOSTICS: SERVICE LAUNCHES
    • TABLE 693 QUEST DIAGNOSTICS: DEALS
    • 12.1.3 ABBOTT
    • TABLE 694 ABBOTT: COMPANY OVERVIEW
    • FIGURE 54 ABBOTT: COMPANY SNAPSHOT (2023)
    • TABLE 695 ABBOTT: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 12.1.4 ORASURE TECHNOLOGIES INC.
    • TABLE 696 ORASURE TECHNOLOGIES INC.: COMPANY OVERVIEW
    • FIGURE 55 ORASURE TECHNOLOGIES INC.: COMPANY SNAPSHOT (2023)
    • TABLE 697 ORASURE TECHNOLOGIES INC.: PRODUCTS/SERVICES/ SOLUTIONS OFFERED
    • TABLE 698 ORASURE TECHNOLOGIES INC.: DEALS
    • 12.1.5 ALFA SCIENTIFIC DESIGNS INC.
    • TABLE 699 ALFA SCIENTIFIC DESIGNS INC.: COMPANY OVERVIEW
    • TABLE 700 ALFA SCIENTIFIC DESIGNS INC.: PRODUCTS/SERVICES/ SOLUTIONS OFFERED
    • 12.1.6 THERMO FISHER SCIENTIFIC INC.
    • TABLE 701 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
    • FIGURE 56 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
    • TABLE 702 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/ SOLUTIONS OFFERED
    • TABLE 703 THERMO FISHER SCIENTIFIC INC.: PRODUCT DEVELOPMENTS
    • TABLE 704 THERMO FISHER SCIENTIFIC INC.: DEALS
    • 12.1.7 DRAGERWERK AG & CO. KGAA
    • TABLE 705 DRAGERWERK AG & CO. KGAA: COMPANY OVERVIEW
    • FIGURE 57 DRAGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2023)
    • TABLE 706 DRAGERWERK AG & CO. KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 707 DRAGERWERK AG & CO. KGAA: PRODUCT LAUNCHES AND APPROVALS
    • 12.1.8 LIFELOC TECHNOLOGIES, INC.
    • TABLE 708 LIFELOC TECHNOLOGIES, INC.: COMPANY OVERVIEW
    • FIGURE 58 LIFELOC TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
    • TABLE 709 LIFELOC TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 12.1.9 MPD INC.
    • TABLE 710 MPD INC.: COMPANY OVERVIEW
    • TABLE 711 MPD INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 12.1.10 OMEGA LABORATORIES, INC.
    • TABLE 712 OMEGA LABORATORIES, INC.: COMPANY OVERVIEW
    • TABLE 713 OMEGA LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 714 OMEGA LABORATORIES, INC.: SERVICE LAUNCHES
    • TABLE 715 OMEGA LABORATORIES, INC.: DEALS
    • TABLE 716 OMEGA LABORATORIES, INC.: OTHER DEVELOPMENTS
    • 12.1.11 PREMIER BIOTECH, INC.
    • TABLE 717 PREMIER BIOTECH, INC.: COMPANY OVERVIEW
    • TABLE 718 PREMIER BIOTECH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 12.1.12 PSYCHEMEDICS CORPORATION
    • TABLE 719 PSYCHEMEDICS CORPORATION: COMPANY OVERVIEW
    • FIGURE 59 PSYCHEMEDICS CORPORATION: COMPANY SNAPSHOT (2023)
    • TABLE 720 PSYCHEMEDICS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 12.1.13 F. HOFFMANN-LA ROCHE LTD.
    • TABLE 721 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
    • FIGURE 60 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023)
    • TABLE 722 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 12.1.14 SHIMADZU CORPORATION
    • TABLE 723 SHIMADZU CORPORATION: COMPANY OVERVIEW
    • FIGURE 61 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2023)
    • TABLE 724 SHIMADZU CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 725 SHIMADZU CORPORATION: PRODUCT LAUNCHES
    • 12.1.15 SIEMENS HEALTHINEERS AG
    • TABLE 726 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
    • FIGURE 62 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)
    • TABLE 727 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 728 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES
    • TABLE 729 SIEMENS HEALTHINEERS AG: DEALS
  • 12.2 OTHER PLAYERS
    • 12.2.1 AMERICAN BIO MEDICA CORPORATION
    • TABLE 730 AMERICAN BIO MEDICA CORPORATION: COMPANY OVERVIEW
    • 12.2.2 ACM GLOBAL LABORATORIES
    • TABLE 731 ACM GLOBAL LABORATORIES: COMPANY OVERVIEW
    • 12.2.3 CAREHEALTH AMERICA CORP.
    • TABLE 732 CAREHEALTH AMERICA CORP.: COMPANY OVERVIEW
    • 12.2.4 CLINICAL REFERENCE LABORATORY, INC.
    • TABLE 733 CLINICAL REFERENCE LABORATORY, INC.: COMPANY OVERVIEW
    • 12.2.5 INTOXIMETERS
    • TABLE 734 INTOXIMETERS: COMPANY OVERVIEW
    • 12.2.6 SCITECK, INC.
    • TABLE 735 SCITECK, INC.: COMPANY OVERVIEW
    • 12.2.7 ACCUSOURCEHR, INC.
    • TABLE 736 ACCUSOURCEHR, INC.: COMPANY OVERVIEW
    • 12.2.8 CORDANT HEALTH SOLUTIONS
    • TABLE 737 CORDANT HEALTH SOLUTIONS: COMPANY OVERVIEW
    • 12.2.9 INTOXALOCK
    • TABLE 738 INTOXALOCK: COMPANY OVERVIEW
    • 12.2.10 MILLENNIUM HEALTH
    • TABLE 739 MILLENNIUM HEALTH: COMPANY OVERVIEW
    • 12.2.11 ADVACARE PHARMA
    • TABLE 740 ADVACARE PHARMA: COMPANY OVERVIEW
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS